Filter
108
Filtered Results: 108
Text search:
drug
import/export
procedures
Featured
Recommendations
8
New Publications
34
Language
Document type
No document type
58
Guidelines
25
Studies & Reports
16
Strategic & Response Plan
6
Manuals
2
Situation Updates
1
Countries / Regions
Zimbabwe
5
Nepal
5
South Africa
5
Uganda
4
Zambia
4
Sierra Leone
3
Liberia
3
Nigeria
3
India
3
Kenya
3
Tanzania
3
Senegal
2
Ethiopia
2
Ghana
2
Bangladesh
2
Eswatini/ Swaziland
2
Myanmar / Burma
2
Western and Central Europe
2
Haiti
1
Philippines
1
Syria
1
Thailand
1
Rwanda
1
Malawi
1
Mozambique
1
Argentina
1
Namibia
1
Peru
1
Brazil
1
Colombia
1
Botswana
1
Bolivia
1
Lesotho
1
Sri Lanka
1
Chile
1
South–East Asia Region
1
Latin America and the Carribbean
1
Asia
1
Venezuela
1
Poland
1
Laos
1
Moldova
1
Iran
1
Global
1
Vietnam
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
53
Clinical Guidelines
5
Key Resources
5
Women & Child Health
3
Pharmacy & Technologies
3
Public Health
1
Toolboxes
AMR
17
Pharmacy
14
HIV
7
Mental Health
6
COVID-19
5
TB
2
Caregiver
2
Ebola
1
Conflict
1
Natural Hazards
1
Rapid Response
1
Specific Hazards
1
Planetary Health
1
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping lab...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3: ...-related harms and responses
- Annex: National data tables
Available in 24 languages on:
http://www.emcdda.europa.eu/publications/edr/trends-developments/2018
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of ... resistance is increasing due to the increasing cost of treatment, prolonged treatment,. That will affect patients’ health, community and social development. In the future, many
nations will be able to face the possibility of having no effective drugs to treat infectious diseases if they do not make appropriate interventions.
Accessed: 28.03.2019
EMCDDA Insights - 11
Accessed: 14.03.2019
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Ins...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
